Page last updated: 2024-08-16

u 78517f and Injury, Myocardial Reperfusion

u 78517f has been researched along with Injury, Myocardial Reperfusion in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guo, CH; Lai, LN; Lei, JW; Song, LH; Song, XL; Zhang, XJ; Zhang, XY1
Hartman, JC; Linseman, DA; Wall, TM1
Altavilla, D; Avenoso, A; Campo, GM; Campo, S; Caputi, AP; Ferlito, M; Squadrito, F; Squadrito, G1

Other Studies

3 other study(ies) available for u 78517f and Injury, Myocardial Reperfusion

ArticleYear
Lazaroid U83836E protects the heart against ischemia reperfusion injury via inhibition of oxidative stress and activation of PKC.
    Molecular medicine reports, 2016, Volume: 13, Issue:5

    Topics: Animals; Cell Membrane; Chromans; Cytoplasm; Enzyme Activation; Male; Myocardial Reperfusion Injury; Myocardium; Oxidative Stress; Piperazines; Protein Kinase C-epsilon; Protein Transport; Rats; Rats, Sprague-Dawley; Signal Transduction

2016
The trolox analog, U-78517F, attenuates hypoxic injury in isolated cardiac myocytes.
    Journal of molecular and cellular cardiology, 1994, Volume: 26, Issue:9

    Topics: Animals; Animals, Newborn; Antioxidants; Cell Hypoxia; Chromans; Creatine Kinase; Heart; In Vitro Techniques; L-Lactate Dehydrogenase; Myocardial Reperfusion Injury; Piperazines; Rats; Rats, Sprague-Dawley; Sarcolemma; Sulfhydryl Compounds

1994
Antioxidant activity of U-83836E, a second generation lazaroid, during myocardial ischemia/reperfusion injury.
    Free radical research, 1997, Volume: 27, Issue:6

    Topics: Aldehydes; Animals; Antioxidants; Cardiovascular System; Chromans; Free Radical Scavengers; Hydroxyl Radical; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Pancreatic Elastase; Piperazines; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Vitamin E

1997